In an effort to mitigate the impact of supply chain disruptions on the availability of critical medicines, the US government is launching a new initiative to cultivate domestic supplies of key pharmaceutical ingredients. The focus is on two specific crops: cannabis and opium poppies. These plants are essential for the production of various medications, and a reliable domestic source is seen as a crucial step towards ensuring a steady supply of these vital drugs.